571-765-7700
Moderna’s COVID-19 Vaccine May Infringe Valid Patent
|
After holding Moderna has standing to appeal an adverse Inter Partes Review decision, Federal Circuit upholds patent over Moderna’s challenge. Concerning another adverse decision in an IPR against a different patent, Moderna found not to have standing to appeal.
Moderna’s COVID-19 Vaccine May Infringe Valid Patent
|
After holding Moderna has standing to appeal an adverse Inter Partes Review decision, Federal Circuit upholds patent over Moderna’s challenge. Concerning another adverse decision in an IPR against a different patent, Moderna found not to have standing to appeal.
Look Around the Archives